The Kentucky Neuroscience Institute is discovering new and advanced ways to bring findings from the researcher's lab bench to the patient's bedside through clinical trials and research grants. By combining the expertise of researchers and physicians, KNI can offer the most advanced treatments.
Patients involved in research trials for neurodegenerative diseases are also monitored and evaluated for a longer period of time in comparison to the typical 60 day study. Factors such as ease of movement, communication and overall satisfaction with life are examined from a longitudinal approach. Such studies include the first North American Phase I clinical trial for Parkinson's disease.
The Kentucky Neuroscience Institute recruits top researchers in the quest to find revolutionary treatments and cures. To learn more about how the University of Kentucky is improving the lives of Americans, please visit the UK's research website.
If you are interested in learning more about clinical trials opportunities within the University of Kentucky, please visit UK's clinical trials website.